Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

We conducted a Phase I clinical trial investigating the biologic activity of vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor in patients with metastatic melanoma. Immunization sites were intensely infiltrated with T l...

Descripció completa

Dades bibliogràfiques

Publicat a:	Proc Natl Acad Sci U S A
Autors principals:	Soiffer, Robert, Lynch, Thomas, Mihm, Martin, Jung, Ken, Rhuda, Catherine, Schmollinger, Jan C., Hodi, F. Stephen, Liebster, Laura, Lam, Prudence, Mentzer, Steven, Singer, Samuel, Tanabe, Kenneth K., Cosimi, A. Benedict, Duda, Rosemary, Sober, Arthur, Bhan, Atul, Daley, John, Neuberg, Donna, Parry, Gordon, Rokovich, Joseph, Richards, Laurie, Drayer, Jan, Berns, Anton, Clift, Shirley, Cohen, Lawrence K., Mulligan, Richard C., Dranoff, Glenn
Format:	Artigo
Idioma:	Inglês
Publicat:	National Academy of Sciences 1998
Matèries:	Biological Sciences
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC23738/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9789055/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.95.22.13141
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!